In the past 25 years, genetically altered mouse models, such as the apolipoprotein E (ApoE) deficient (Apoe−/−) mouse, have been studied to understand the underlying pathophysiological mechanisms of cardiovascular disease and the development of therapies1,2. Here, APOE is linked to cardiovascular disorder.